CVX vs KALA · P/E 17, rev $118.66B vs $54.3M cap
Chevron Corp (CVX) versus Kala Pharmaceuticals Inc (KALA) — a side-by-side from cached financials, not a winner call.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Mike Wirth.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
CVX currently screens at market cap $250.20B and trailing P/E 16.5. KALA currently screens at market cap $54.3M.
Not investment advice. Open the CVX and KALA stock pages for the full models.
Not investment advice.